PTGX
NASDAQ
$134.27
Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $125.15 (-6.79%)
Market Cap
$8.70B
Free Cash Flow Yield
-1.36%
Beta (5Y)
0.21
Price Chart
Valuation
Market Cap$8.70B
Forward P/E29.85
P/S113.99
P/B12.89
Profitability
Total Revenue (TTM)$74M
Gross Profit (TTM)$74M
EBITDA-$141M
Profit Margin6.7%
Operating Margin-6.5%
EPS-$1.84
Financial Health
Free Cash Flow Yield-1.36%
Growth & Risk
EPS 5Y CAGR+1.43%
Revenue 5Y CAGR+16.30%
FCF 5Y CAGR+6.55%
Beta (5Y)0.21
Sharpe Ratio1.85